iRhythm Holdings (IRTC) Net Cash Flow Growth (3y) (2018 - 2026)
iRhythm Holdings (IRTC) Net Cash Flow Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | -48.90% |
| 10 | iRhythm Holdings | 3.69 Bn | 3.14 Bn | 141.35 Mn | 29.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.29% |
| Dec 31, 2025 | -66.06% |
| Sep 30, 2025 | -21.22% |
| Jun 30, 2025 | -130.40% |
| Mar 31, 2025 | -10.57% |
| Dec 31, 2024 | -35.91% |
| Sep 30, 2024 | -45.63% |
| Jun 30, 2024 | 172.04% |
| Mar 31, 2024 | 116.20% |
| Dec 31, 2023 | -18.29% |
| Sep 30, 2023 | -44.89% |
| Jun 30, 2023 | -29.55% |
| Mar 31, 2023 | -39.62% |
| Dec 31, 2022 | 36.39% |
| Sep 30, 2022 | -53.41% |
| Jun 30, 2022 | 36.33% |
| Mar 31, 2022 | -82.29% |
| Dec 31, 2021 | -156.45% |
| Sep 30, 2021 | 157.28% |
| Jun 30, 2021 | -18.53% |